Hydroxytyrosol attenuates peripheral neuropathy in streptozotocin-induced diabetes in rats.

Peripheral neuropathy is one of the most frequent and severe complications of diabetes. Hydroxytyrosol (HT), the major antioxidant polyphenolic compound of olive oil, has been investigated as a new potential treatment to counteract the progression of peripheral diabetic neuropathy in rats. An established model of streptozotocin-induced diabetes has been used. After confirmation of hyperglycemia, diabetic and nondiabetic animals were randomized to receive either a low dose or a high dose of HT, or the corresponding vehicle, for 6 weeks. At the end of the 6-week period of treatment, HT blunted plasma thiobarbituric acid-reactive substances increase (p < 0.05) and significantly reduced nerve conduction velocity (p < 0.05) and thermal nociception impairment in diabetic rats (p < 0.05). Sciatic nerve Na(+), K(+)-ATPase activity reduction was also abolished by HT (p < 0.05). The present study provides evidence of the therapeutic potential of the natural substance hydroxytyrosol in the early stage of diabetic neuropathy.

[1]  K. Wertz,et al.  Mitochondrial dynamic remodeling in strenuous exercise-induced muscle and mitochondrial dysfunction: regulatory effects of hydroxytyrosol. , 2011, Free radical biology & medicine.

[2]  B. Sarriá,et al.  Alkyl hydroxytyrosyl ethers show protective effects against oxidative stress in HepG2 cells. , 2011, Journal of agricultural and food chemistry.

[3]  G. Cavaletti,et al.  Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: A correlation with the levels of neuroactive steroids in the sciatic nerve , 2011, Experimental Neurology.

[4]  M. Ghoul,et al.  Hydroxytyrosol Acyl Esters: Biosynthesis and Activities , 2011, Applied biochemistry and biotechnology.

[5]  G. Cavaletti,et al.  Activation of the Liver X Receptor Increases Neuroactive Steroid Levels and Protects from Diabetes-Induced Peripheral Neuropathy , 2010, The Journal of Neuroscience.

[6]  Sami Sayadi,et al.  Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. , 2009, Journal of agricultural and food chemistry.

[7]  N. Allouche,et al.  Hypoglycemic and antioxidant effects of phenolic extracts and purified hydroxytyrosol from olive mill waste in vitro and in rats. , 2009, Chemico-biological interactions.

[8]  Xiaomei Zhang,et al.  Hydroxytyrosol inhibits pro-inflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  Liping Jiang,et al.  Inhibition of acrylamide genotoxicity in human liver-derived HepG2 cells by the antioxidant hydroxytyrosol. , 2008, Chemico-biological interactions.

[10]  G. Said,et al.  Diabetic neuropathy—a review , 2007, Nature Clinical Practice Neurology.

[11]  T. Meert,et al.  The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy , 2007, Neuroscience Letters.

[12]  G. Cavaletti,et al.  Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis , 2007, Neuroscience.

[13]  M. Dobretsov,et al.  Early diabetic neuropathy: triggers and mechanisms. , 2007, World journal of gastroenterology.

[14]  G. Panayotou,et al.  Biological activity of acetylated phenolic compounds. , 2007, Journal of agricultural and food chemistry.

[15]  M. Soni,et al.  Safety assessment of aqueous olive pulp extract as an antioxidant or antimicrobial agent in foods. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  L. Padua,et al.  Multi‐center assessment of the Total Neuropathy Score for chemotherapy‐induced peripheral neurotoxicity , 2006, Journal of the peripheral nervous system : JPNS.

[17]  Danny R. Bedgood,et al.  Bioactivity and analysis of biophenols recovered from olive mill waste. , 2005, Journal of agricultural and food chemistry.

[18]  P. Ghezzi,et al.  Erythropoietin both protects from and reverses experimental diabetic neuropathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Hoberman,et al.  The Toxicity Profile of Hydrolyzed Aqueous Olive Pulp Extract , 2004, Drug and chemical toxicology.

[20]  A. Sima,et al.  New insights into the metabolic and molecular basis for diabetic neuropathy , 2003, Cellular and Molecular Life Sciences CMLS.

[21]  Z. Madar,et al.  Olive oil as a functional food: epidemiology and nutritional approaches. , 2002, Nutrition reviews.

[22]  V. Zappia,et al.  Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[23]  S. Pierre,et al.  Localization of Na,K‐ATPase α/β Isoforms in Rat Sciatic Nerves : Effect of Diabetes and Fish Oil Treatment , 1999 .

[24]  K. Sekiya,et al.  Determination of Synthetic Hydroxytyrosol in Rat Plasma by GC-MS , 1998 .

[25]  V. Zappia,et al.  The protective effect of the olive oil polyphenol (3,4-dihydroxyphenyl)-ethanol counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells. , 1997, The Journal of nutrition.

[26]  E. Scarpini,et al.  Decrease of nerve Na+,K+-ATPase activity in the pathogenesis of human diabetic neuropathy , 1993, Journal of the Neurological Sciences.

[27]  D. Greene,et al.  Overt Diabetic Neuropathy: Repair of Axo‐glial Dysjunction and Axonal Atrophy by Aldose Reductase Inhibition and its Correlation to Improvement in Nerve Conduction Velocity , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[28]  P. Marini,et al.  ATPase Activity Defects in Alloxan-Induced Diabetic Sciatic Nerve Recovered by Ganglioside Treatment , 1988, Diabetes.

[29]  J. Adler,et al.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy , 1987, Diabetologia.

[30]  0163-769X/04/$20.00/0 Endocrine Reviews 25(4):612–628 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/er.2003-0019 Oxidative Stress in the Pathogenesis of , 2022 .